NewAmsterdam Pharma Company NV (NAMS) Earnings Report - Forecasts and Surprise Ratio

Quarterly Earnings History

NAMS ratio: 67%

100%

NAMS beat 2 of 3 last estimates

Date of next report: Feb 26, 2025

Estimate for Q4 24: $-0.44

Implied change from Q3 24: +144.44%

Implied change from Q4 23: 0.00%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q3 24	Nov 6, 2024	$-0.18 / $-0.48	$0.3 / 62.5%
Q2 24	Aug 7, 2024	$-0.51 / $-0.59	$0.08 / 13.56%
Q1 24	May 8, 2024	$-0.62 / $-0.54	$-0.08 / -14.81%

Data Vendor: Xignite Logo